Standardized Instruments to Provide Diagnostic and Prognostic Information in Mild Traumatic Brain Injury (mTBI)
Key facts
- Who runs it
- Carey Balaban
- Where
- Miami, Pittsburgh, and San Diego, United StatesSee the 3 sites
- Trial code
- Status
- Completed
- People taking part
- 161 people enrolled
- Started
- 30 Sept 2020
- Ended
- 31 Mar 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Diagnostic test
- Record updated
- 22 January 2026
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- For the mTBI group, participants must present to a recruitment site within 10 days of injury with a diagnosed concussion that meets all of the following criteria:
- clear mechanism of injury (i.e., direct or indirect impact to head),
- Glasgow Coma Scale= 13-15, 3) observed or reported signs (e.g., loss of consciousness, amnesia, or confusion) or symptoms (e.g., headache, dizziness, nausea), and
- neurosensory symptoms; For Control group, participants will have minor, non-surgical injuries (e.g., sprains, strains) not requiring hospital admission and no history of mTBI will be recruited from the same study sites
Who cannot take part
- mTBI history; mTBI Group - history of mTBI within the last 6 months or experiencing head injury symptoms immediately prior to the current head injury or history of 3 or more mTBIs; Controls - No history of mTBI within the last 12 months and no presence of any mTBI-related symptoms at time of enrollment
- Prior disorders of hearing and balance including:; Meniere's disease; Multiple sclerosis; Vestibular neuritis; Vestibular schwannoma; Sudden sensorineural hearing loss
- History of moderate to severe TBI characterized by any of the following:; Penetrating head trauma; GCS< 13 at the time of injury; Associated with LOC > 30 minutes or amnesia >24 hours; Associated with subdural or epidural hemorrhage
- History of diagnosed psychiatric disorder (e.g., schizophrenia)
- Documented neurological disorders (e.g., Epilepsy, stroke, dementia)
- History of tumor of the brain or central nervous system
- Presence of severe aphasia
- Pregnancy (females will be asked if they are pregnant)
Where in United States
- University of MiamiMiami, United States
- University of PittsburghPittsburgh, United States
- Naval Medical Center -San DiegoSan Diego, United States
About the trial
What the trial wants to find out
This study will establish the capability of a suite of conventional tests and the Neurolign Dx_100 I-PAS goggle system to reliably and objectively detect mTBI in an acute setting when comparing individuals with mTBI to controls with minor injuries in a similarly stressful environment.
The 2 groups in the trial
- Mild Traumatic Brain Injury ParticipantsTreatment being tested
Males and females from 18-50 years of age who present to a recruitment site within 10 days of injury with a diagnosed concussion that meets all of the following criteria: 1) clear mechanism of injury (i.e., direct or indirect impact to head), 2) Glasgow Coma Scale= 13-15, 3) observed or reported signs (e.g., loss of consciousness, amnesia, or confusion) or symptoms (e.g., headache, dizziness, nausea), and 3) neurosensory symptoms.
Treatment: Diagnostic test
- Control ParticipantsExisting treatment, for comparison
Age- and sex-matched control subjects with minor, non-surgical injuries (e.g., sprains, strains) not requiring hospital admission and no history of mild traumatic brain injury will be recruited from the same study sites.
Treatment: Diagnostic test
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 22 January 2026